Adage Capital Partners’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-443,000
| Closed | -$6.6M | – | 921 |
|
|
2024
Q4 | $6.6M | Buy |
+443,000
| New | +$6.6M | 0.01% | 679 |
|
|
2022
Q2 | – | Sell |
-75,000
| Closed | -$2.37M | – | 1134 |
|
|
2022
Q1 | $2.37M | Hold |
75,000
| – | – | ﹤0.01% | 886 |
|
|
2021
Q4 | $3.04M | Hold |
75,000
| – | – | 0.01% | 852 |
|
|
2021
Q3 | $2.62M | Hold |
75,000
| – | – | 0.01% | 881 |
|
|
2021
Q2 | $2.06M | Sell |
75,000
-175,000
| -70% | -$4.81M | ﹤0.01% | 879 |
|
|
2021
Q1 | $7.02M | Hold |
250,000
| – | – | 0.01% | 758 |
|
|
2020
Q4 | $6.49M | Hold |
250,000
| – | – | 0.01% | 660 |
|
|
2020
Q3 | $4.29M | Hold |
250,000
| – | – | 0.01% | 658 |
|
|
2020
Q2 | $6.19M | Buy |
+250,000
| New | +$6.19M | 0.02% | 591 |
|